ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 352 filers reported holding ICU MED INC in Q3 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,125,381 | +250.1% | 26,319 | +216.4% | 0.00% | – |
Q1 2024 | $892,795 | +7.1% | 8,319 | -0.5% | 0.00% | – |
Q4 2023 | $833,627 | -74.5% | 8,358 | -69.6% | 0.00% | -100.0% |
Q3 2023 | $3,272,775 | -38.7% | 27,500 | -8.2% | 0.00% | -50.0% |
Q2 2023 | $5,337,860 | +9.7% | 29,956 | +1.5% | 0.00% | 0.0% |
Q1 2023 | $4,866,815 | +2.3% | 29,503 | -2.4% | 0.00% | 0.0% |
Q4 2022 | $4,759,203 | +5.2% | 30,221 | +0.6% | 0.00% | 0.0% |
Q3 2022 | $4,526,000 | -9.1% | 30,052 | -0.8% | 0.00% | 0.0% |
Q2 2022 | $4,981,000 | -25.2% | 30,298 | +1.3% | 0.00% | -33.3% |
Q1 2022 | $6,658,000 | -8.2% | 29,903 | -2.2% | 0.00% | 0.0% |
Q4 2021 | $7,255,000 | +1.9% | 30,568 | +0.2% | 0.00% | 0.0% |
Q3 2021 | $7,121,000 | +12.4% | 30,511 | -0.9% | 0.00% | 0.0% |
Q2 2021 | $6,334,000 | -2.6% | 30,779 | -2.8% | 0.00% | 0.0% |
Q1 2021 | $6,506,000 | -2.9% | 31,667 | +1.4% | 0.00% | 0.0% |
Q4 2020 | $6,701,000 | +15.5% | 31,241 | -1.6% | 0.00% | 0.0% |
Q3 2020 | $5,804,000 | -2.3% | 31,759 | -1.4% | 0.00% | 0.0% |
Q2 2020 | $5,938,000 | -8.3% | 32,219 | +0.5% | 0.00% | -40.0% |
Q1 2020 | $6,472,000 | +7.7% | 32,074 | -0.1% | 0.01% | +66.7% |
Q4 2019 | $6,007,000 | +19.8% | 32,104 | +2.2% | 0.00% | 0.0% |
Q3 2019 | $5,014,000 | -32.6% | 31,414 | +6.5% | 0.00% | -40.0% |
Q2 2019 | $7,434,000 | +15.4% | 29,510 | +9.7% | 0.01% | +25.0% |
Q1 2019 | $6,440,000 | -15.5% | 26,910 | -18.9% | 0.00% | -33.3% |
Q4 2018 | $7,617,000 | +72.0% | 33,170 | +111.8% | 0.01% | +100.0% |
Q3 2018 | $4,428,000 | -4.1% | 15,660 | -0.4% | 0.00% | 0.0% |
Q2 2018 | $4,616,000 | -35.8% | 15,720 | -44.8% | 0.00% | -40.0% |
Q1 2018 | $7,188,000 | +25.0% | 28,478 | +6.9% | 0.01% | +25.0% |
Q4 2017 | $5,752,000 | +37.1% | 26,628 | +18.0% | 0.00% | +33.3% |
Q3 2017 | $4,194,000 | +7.7% | 22,568 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $3,893,000 | +12.5% | 22,568 | -0.4% | 0.00% | 0.0% |
Q1 2017 | $3,461,000 | +1.8% | 22,668 | -1.7% | 0.00% | 0.0% |
Q4 2016 | $3,399,000 | +16.6% | 23,068 | 0.0% | 0.00% | +50.0% |
Q3 2016 | $2,915,000 | +12.1% | 23,068 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $2,601,000 | +12.7% | 23,068 | +4.1% | 0.00% | 0.0% |
Q1 2016 | $2,308,000 | -7.7% | 22,168 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $2,500,000 | -7.8% | 22,168 | -10.5% | 0.00% | 0.0% |
Q3 2015 | $2,712,000 | +14.4% | 24,768 | -0.1% | 0.00% | 0.0% |
Q2 2015 | $2,371,000 | +13.2% | 24,788 | +10.2% | 0.00% | 0.0% |
Q1 2015 | $2,095,000 | +13.7% | 22,488 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,842,000 | +22.2% | 22,488 | -4.3% | 0.00% | +100.0% |
Q3 2014 | $1,507,000 | +5.5% | 23,488 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,428,000 | -7.2% | 23,488 | -8.6% | 0.00% | 0.0% |
Q1 2014 | $1,538,000 | -6.0% | 25,690 | +0.0% | 0.00% | 0.0% |
Q4 2013 | $1,636,000 | -6.2% | 25,681 | +0.0% | 0.00% | -50.0% |
Q3 2013 | $1,744,000 | -3.4% | 25,676 | +2.5% | 0.00% | 0.0% |
Q2 2013 | $1,806,000 | – | 25,058 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NUANCE INVESTMENTS, LLC | 1,361,508 | $280,198,000 | 5.00% |
EVR Research LP | 22,000 | $4,528,000 | 2.63% |
Nitorum Capital, L.P. | 252,668 | $51,999,000 | 2.37% |
Tamarack Advisers, LP | 34,000 | $6,997,000 | 1.98% |
PFM Health Sciences, LP | 255,708 | $52,625,000 | 1.65% |
KIRR MARBACH & CO LLC /IN/ | 22,645 | $4,660,000 | 1.32% |
PURA VIDA INVESTMENTS, LLC | 149,802 | $30,829,000 | 0.96% |
Findlay Park Partners LLP | 655,299 | $134,861,000 | 0.92% |
Canvas Wealth Advisors, LLC | 7,578 | $1,560,000 | 0.70% |
Redmile Group, LLC | 222,929 | $45,879,000 | 0.68% |